Mumbai, March 23 -- The World Health Organisation's (WHO) plan to reduce the treatment regimen for multidrug resistant (MDR) tuberculosis to nine months from two years may not benefit a majority of the city's 4,969 patients, according to a study published in a scientific journal, BMC Infectious Diseases, ahead of the World TB Day (March 24). The reason: Their resistance to second-line drugs....